[Clinical studies on cefpiramide].
A new cephalosporin, cefpiramide was administered to 12 patients with gynecological infections and the clinical effects obtained were good in 11 cases and poor in 1 (effective ratio: 91.7%). No side effects were observed except for eruption in 1 case, however, the relationship between the drug and eruption was unknown. No abnormalities were observed in hematological, hepatic and renal tests.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged
D002511:Cephalosporins; C036666:cefpiramide